Clinical trial
Safety and Efficacy of Pravastatin in Relapsing-remitting Multiple Sclerosis
NCT00200655
Study timeline
Study start (unknown)2004-12-01Date precision: month
Registry last updated2016-04-28
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Relapsing-remitting Multiple Sclerosisunresolved
Interventions
PravastatinDRUG · verified · RxNorm: pravastatin
PlaceboDRUG
Sponsors & collaborators
Nantes University Hospitallead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00200655 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.